Thieler Law Corp advises investors with losses exceeding $100,000 of the April 10, 2017 lead plaintiff deadline in a class action lawsuit filed against Kitov Pharmaceuticals Holdings LTD (NASDAQ: KTOV) (“Kitov” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Kitov Pharmaceuticals Holdings LTD securities at Company's initial public offering on or about November 20, 2015 (the "IPO") and/or on the open market between November 20, 2015 and February 3, 2017, have until April 10, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Kitov Pharmaceuticals Holdings LTD securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that the Company and its Chief Executive Officer Isaac Israel published misleading information concerning the conduct of the Company’s clinical trials for its lead drug candidate KIT-302; and as a result of the foregoing, Kitov’s public statements were materially false and misleading at all relevant times.

On February 6, 2017, the Israeli publication Calcalist revealed that Kitov's Chief Executive Officer, had been detained by the Israeli Securities Authority due to allegations of publishing misleading information regarding a recent clinical trial of one of Kitov's products.

Upon the release of this news, the value of Kitov stock fell, causing investors harm.

If you were negatively impacted by your investment in Kitov Pharmaceuticals Holdings LTD securities from the Company's initial public offering on or about November 20, 2015 (the "IPO") and/or on the open market between November 20, 2015 and February 3, 2017and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185